S&P 500   4,237.99 (+0.73%)
DOW   33,478.71 (+0.43%)
QQQ   326.83 (+0.85%)
AAPL   170.45 (+1.16%)
MSFT   288.50 (+0.52%)
META   180.13 (+1.49%)
GOOGL   119.86 (+0.86%)
AMZN   140.70 (+0.04%)
TSLA   875.75 (+1.84%)
NVDA   184.46 (+2.81%)
NIO   20.71 (-0.53%)
BABA   92.99 (-1.98%)
AMD   100.64 (+2.57%)
MU   63.78 (+2.34%)
T   18.14 (+0.55%)
CGC   3.27 (+3.81%)
GE   78.84 (-0.08%)
F   16.00 (+1.07%)
DIS   120.49 (+2.38%)
AMC   25.71 (+0.98%)
PYPL   100.37 (+1.27%)
PFE   49.35 (+2.20%)
NFLX   245.20 (+1.03%)
S&P 500   4,237.99 (+0.73%)
DOW   33,478.71 (+0.43%)
QQQ   326.83 (+0.85%)
AAPL   170.45 (+1.16%)
MSFT   288.50 (+0.52%)
META   180.13 (+1.49%)
GOOGL   119.86 (+0.86%)
AMZN   140.70 (+0.04%)
TSLA   875.75 (+1.84%)
NVDA   184.46 (+2.81%)
NIO   20.71 (-0.53%)
BABA   92.99 (-1.98%)
AMD   100.64 (+2.57%)
MU   63.78 (+2.34%)
T   18.14 (+0.55%)
CGC   3.27 (+3.81%)
GE   78.84 (-0.08%)
F   16.00 (+1.07%)
DIS   120.49 (+2.38%)
AMC   25.71 (+0.98%)
PYPL   100.37 (+1.27%)
PFE   49.35 (+2.20%)
NFLX   245.20 (+1.03%)
S&P 500   4,237.99 (+0.73%)
DOW   33,478.71 (+0.43%)
QQQ   326.83 (+0.85%)
AAPL   170.45 (+1.16%)
MSFT   288.50 (+0.52%)
META   180.13 (+1.49%)
GOOGL   119.86 (+0.86%)
AMZN   140.70 (+0.04%)
TSLA   875.75 (+1.84%)
NVDA   184.46 (+2.81%)
NIO   20.71 (-0.53%)
BABA   92.99 (-1.98%)
AMD   100.64 (+2.57%)
MU   63.78 (+2.34%)
T   18.14 (+0.55%)
CGC   3.27 (+3.81%)
GE   78.84 (-0.08%)
F   16.00 (+1.07%)
DIS   120.49 (+2.38%)
AMC   25.71 (+0.98%)
PYPL   100.37 (+1.27%)
PFE   49.35 (+2.20%)
NFLX   245.20 (+1.03%)
S&P 500   4,237.99 (+0.73%)
DOW   33,478.71 (+0.43%)
QQQ   326.83 (+0.85%)
AAPL   170.45 (+1.16%)
MSFT   288.50 (+0.52%)
META   180.13 (+1.49%)
GOOGL   119.86 (+0.86%)
AMZN   140.70 (+0.04%)
TSLA   875.75 (+1.84%)
NVDA   184.46 (+2.81%)
NIO   20.71 (-0.53%)
BABA   92.99 (-1.98%)
AMD   100.64 (+2.57%)
MU   63.78 (+2.34%)
T   18.14 (+0.55%)
CGC   3.27 (+3.81%)
GE   78.84 (-0.08%)
F   16.00 (+1.07%)
DIS   120.49 (+2.38%)
AMC   25.71 (+0.98%)
PYPL   100.37 (+1.27%)
PFE   49.35 (+2.20%)
NFLX   245.20 (+1.03%)
NASDAQ:LNDC

Landec - LNDC Stock Forecast, Price & News

$11.27
-0.04 (-0.35%)
(As of 08/12/2022 10:58 AM ET)
Add
Compare
Today's Range
$11.25
$11.39
50-Day Range
$9.50
$11.31
52-Week Range
$7.65
$12.04
Volume
884 shs
Average Volume
56,419 shs
Market Capitalization
$332.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00

Landec MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
21.3% Upside
$13.67 Price Target
Short Interest
Healthy
1.75% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.50
Upright™ Environmental Score
News Sentiment
0.82mentions of Landec in the last 14 days
Based on 15 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Consumer Staples Sector

86th out of 147 stocks

Canned Fruits & Specialties Industry

1st out of 2 stocks

LNDC stock logo

About Landec (NASDAQ:LNDC) Stock

Landec Corporation, together with its subsidiaries, engages in the design, development, manufacture, and sale of differentiated health and wellness products for food and biomaterials markets. It operates through Curation Foods and Lifecore segments. The Curation Foods segment engages in processing, marketing, and selling of plant-based salads, and fresh-cut and whole processed vegetables primarily under the Eat Smart brand, O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products, as well as various private labels to retail grocery chains, club stores, and food service operators; and sells BreatheWay packaging products. The Lifecore segment manufactures pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products to treat various medical conditions and procedures. It also provides product development services, including technology transfer, material component changes, analytical method and formulation development, pilot and stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. It operates in the United States, Canada, Belgium, Switzerland, Czech Republic, Ireland, and internationally. The company was incorporated in 1986 and is headquartered in Santa Maria, California.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Stephens initiated coverage on shares of Landec in a report on Tuesday, July 19th. They set an "overweight" rating and a $13.00 price objective on the stock. Barrington Research raised shares of Landec from a "market perform" rating to an "outperform" rating and set a $14.00 price target on the stock in a research note on Thursday. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $13.67.

Landec Price Performance

Shares of NASDAQ:LNDC traded down $0.06 during midday trading on Friday, reaching $11.25. 771 shares of the stock traded hands, compared to its average volume of 56,419. The company's 50 day moving average is $10.18 and its 200 day moving average is $10.46. Landec has a one year low of $7.65 and a one year high of $12.04. The stock has a market capitalization of $331.65 million, a PE ratio of -3.44 and a beta of 1.07. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.47 and a quick ratio of 0.65.

Receive LNDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Landec and its competitors with MarketBeat's FREE daily newsletter.

LNDC Stock News Headlines

Landec (LNDC) to Release Earnings on Wednesday
Landec (NASDAQ:LNDC) Now Covered by Stephens
See More Headlines
Receive LNDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Landec and its competitors with MarketBeat's FREE daily newsletter.

LNDC Company Calendar

Last Earnings
9/28/2021
Today
8/12/2022
Next Earnings (Estimated)
10/05/2022
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Canned fruits & specialties
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:LNDC
CUSIP
51476610
Employees
905
Year Founded
1986

Price Target and Rating

Average Stock Price Forecast
$13.67
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$13.00
Forecasted Upside/Downside
+15.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-32,670,000.00
Pretax Margin
-15.04%

Debt

Sales & Book Value

Annual Sales
$185.79 million
Cash Flow
$0.61 per share
Book Value
$6.91 per share

Miscellaneous

Free Float
25,603,000
Market Cap
$332.24 million
Optionable
Optionable
Beta
1.07

Social Links















LNDC Stock - Frequently Asked Questions

Should I buy or sell Landec stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Landec in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LNDC shares.
View LNDC analyst ratings
or view top-rated stocks.

What is Landec's stock price forecast for 2022?

3 Wall Street research analysts have issued 12 month price targets for Landec's stock. Their LNDC share price forecasts range from $13.00 to $14.00. On average, they expect the company's stock price to reach $13.67 in the next twelve months. This suggests a possible upside of 20.8% from the stock's current price.
View analysts price targets for LNDC
or view top-rated stocks among Wall Street analysts.

How have LNDC shares performed in 2022?

Landec's stock was trading at $11.10 at the beginning of the year. Since then, LNDC shares have increased by 1.9% and is now trading at $11.31.
View the best growth stocks for 2022 here
.

When is Landec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 5th 2022.
View our LNDC earnings forecast
.

How were Landec's earnings last quarter?

Landec Co. (NASDAQ:LNDC) announced its earnings results on Tuesday, September, 28th. The basic materials company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.11) by $0.12. The basic materials company earned $128.79 million during the quarter, compared to analysts' expectations of $128.25 million. Landec had a negative net margin of 14.10% and a negative trailing twelve-month return on equity of 8.43%. During the same period last year, the company posted ($0.11) EPS.

What is Gary T. Steele's approval rating as Landec's CEO?

1 employees have rated Landec Chief Executive Officer Gary T. Steele on Glassdoor.com. Gary T. Steele has an approval rating of 100% among the company's employees. This puts Gary T. Steele in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Landec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Landec investors own include Comerica (CMA), Honda Motor (HMC), Walt Disney (DIS), General Mills (GIS), Walmart (WMT), Albemarle (ALB), Cenovus Energy (CVE), Selecta Biosciences (SELB), First Hawaiian (FHB) and General Electric (GE).

What is Landec's stock symbol?

Landec trades on the NASDAQ under the ticker symbol "LNDC."

Who are Landec's major shareholders?

Landec's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Pacific Ridge Capital Partners LLC (1.69%), Russell Investments Group Ltd. (1.01%), Assenagon Asset Management S.A. (0.87%), Employees Retirement System of Texas (0.58%), Deutsche Bank AG (0.39%) and Defender Capital LLC. (0.31%). Insiders that own company stock include Albert D Bolles, James G Hall, John D Morberg, Joshua Schechter, Nelson Obus, Patrick D Walsh, Timothy P Burgess and Wynnefield Partners Small Cap.
View institutional ownership trends
.

How do I buy shares of Landec?

Shares of LNDC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Landec's stock price today?

One share of LNDC stock can currently be purchased for approximately $11.31.

How much money does Landec make?

Landec (NASDAQ:LNDC) has a market capitalization of $333.45 million and generates $544.16 million in revenue each year. The basic materials company earns $-32,670,000.00 in net income (profit) each year or ($2.15) on an earnings per share basis.

How many employees does Landec have?

The company employs 905 workers across the globe.

Does Landec have any subsidiaries?

The following companies are subsidiares of Landec: Apio, Curation Foods Inc., Dock Resins, GreenLine Holding, Heartland Hybrids, Lifecore, O Olive Oil, and Yucatan Foods.
Read More

When was Landec founded?

Landec was founded in 1986.

How can I contact Landec?

Landec's mailing address is 5201 GREAT AMERICA PKWY SUITE 232, SANTA MARIA CA, 93455. The official website for the company is www.landec.com. The basic materials company can be reached via phone at (650) 306-1650, via email at john.mills@icrinc.com, or via fax at 650-368-9818.

This page (NASDAQ:LNDC) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.